Aandeel GRNA GREENLIGHT BIOSCIENCES HOLDINGS PBC
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Greenlight Biosciences Holdings Pbc

Aandelen

GRNA

US39536G1058

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
GreenLight Biosciences Completes Going Private Transaction
GreenLight Biosciences Agrees to be Acquired by Fall Line Capital-Led Group in $45.5 Million Deal
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Reports Q1 Revenue $3.8M
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
GreenLight Biosciences Releases Inaugural Sustainability Report
GreenLight Biosciences Gets Interest Indication From Fall Line Endurance Fund; Shares Rise After-Hours
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Greenlight Biosciences Q4 EPS Loss Narrow, Revenue Rises
GREENLIGHT BIOSCIENCES HOLDINGS, PBC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Earnings Flash (GRNA) GREENLIGHT BIOSCIENCES Reports Q4 Revenue $3M
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
GreenLight Biosciences Secures Rwanda FDA Approval for COVID-19 Clinical Trial
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
GreenLight Biosciences, Epivax Therapeutics to Jointly Develop Personalized Cancer Vaccines
GREENLIGHT BIOSCIENCES HOLDINGS, PBC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers GRNA
  4. Nieuws Greenlight Biosciences Holdings Pbc
  5. Andere talen